Epidemiology of familial prostate cancer: 4-year assessment of French studies;Epidémiologie du cancer de la prostate familial: Bilan à 4 ans des études françaises

Progres en Urologie

Volumn 9, Issue 4, 1999, Pages 672-679

  Valeri, Antoine ^a,b   Drelon, Eric ^a   Azzouzi, Rahmène ^a   Delannoy, Arnaud ^c   Teillac, Pierre ^a   Fournier, Georges ^c   Mangin, Philippe ^c   Berthon, Philippe ^a   Cussenot, Olivier ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c NONE

Author keywords

Epidemiology; Familial; Genetic counselling; Genetics; Hereditary transmission; Prostate cancer

Indexed keywords

AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; COMPARATIVE STUDY; DOMINANT GENE; FEMALE; FRANCE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; PEDIGREE; PROSTATE TUMOR; RISK FACTOR; STATISTICAL ANALYSIS;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DATA INTERPRETATION, STATISTICAL; FEMALE; FRANCE; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0033193717     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AUS G. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment. Scand. J. Urol. Nephrol., 1994, suppl. 167.
2. BERTHON P., VALERI A., COHEN-AKENINE A., DRELON E., PAISS T., WOHR G., LATIL A., MILLASSEAU P., MELLAH I., COHEN B., BLANCHE H., BELLANE-CHANTELOT C., DEMENAIS F., TEILLAC P., LE DUC A., DE PETRICONI R., HAUTMANN R., CHUMAKOV I., BACHNER L., MAITLAND N., LIDEREAU R., VOGEL W., FOURNIER G., MANGIN P., COHEN D., CUSSENOT O. Predisposing gene for early onset prostate cancer localised on chromosome 1q 42.2-43. Am. J. Hum. Genet., 1998, 62, 1416-24.
3. CANNON-ALBRIGHT L., NEUHAUSEN S. Prostate cancer susceptibility locus on chromosome 1 examined in Utah kindreds. Paper presented at Genetic Approaches to Breast and Prostate Cancer, Cambridge Symposia, March 22 -April 17, Cambridge 1997.
4. CARTER B.S., BEATY T.H., STEINBERG G.D., CHILDS B., WALSH P.C. Mendelian inheritance of familial prostate cancer. Proc. Natl. Acad. Sci. USA,. 1992, 89, 3367-3371.
5. CARTER B.S., BOVA G.S., BEATY T.H., STEINBERG G.D., CHILDS B., ISAACS W.B., WALSH P.C. Hereditary prostate cancer epidemiologic and clinical features. J. Urol., 1993, 150, 797-802.
6. COONEY K.A., Mac CARTHY J.D., LANGE E., HUANG L., MIESFELDT S., MONTIE J.E., OESTERLING J.E., SANDLER H.M., LANGE K. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J. Natl. Cancer Inst., 1997, 89, 955-959.
7. DIAMOND T.M., SUTPHEN R., TABANO M., FIORICA J. Inherited susceptibility to breast and ovarian cancer. Curr. Opin. Obstet. Gynecol., 1998, 10, 1, 3-8.
8. EELES R., DUROCHER F., EDWARDS S., TEARE D., EASTON D., DEAMALEY D., SHEARER R., ARDEM-JONES A., DOWE A., BADZIOCH M., AMOS C., LABRIE F., SIMARD J., NAROD S., FOULKES W. Does the hereditary prostate cancer gene, HPC1 contribute to a large proportion of familial prostate cancer? - results from the CRC/BPG UK, Texan &Canadian Consortium. Am. J. Hum. Genet., 1997, Suppl, 61: A64.
9. FOURCADE R.O., ROUSSEAU V., COOSAERT J. Les facteurs de risque du cancer prostatique: étude prospective de 1674 cas. Prog. Urol., 1994, 4, suppl. 1, B 43.
10. FOURNIER G., VALERI A., CUSSENOT O. Formes familiales des cancers de l'appareil urogénital: aspects cliniques et génétiques. Prog. Urol., 1996, 6, 343-55.
11. GHADIRIAN P., CADOTTE M., LACROIX A., PERRET C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. The Prostate, 1991, 19, 43-52.
12. GIBBS M., STANFORD J.L., Mc INDOE R.A., JARVIK G.P., KOLB S., GOODE E.L., CHAKRABARTI L., SCHUSTER E.F., BUCKLEY V.A., MILLER E.L., BRANDZEL S., LI S., HOOD L., OSTRANDER E.E. Evidence for a rare Prostate CancerSusceptibility Locus at chromosome 1p36. Am. J. Hum. Genet.. 1999, 64, 776-787.
13. GRONBERG H., DAMBER L., DAMBER J.E., ISELIUS L. Segregation analysis of prostate cancer in Sweden: support to dominant inheritance. Am. J. Epidemiol., 1997, 146, 552-557.
14. HSIEH C.L., OAKLEY-GIRVAN I., GALLAGHER R.P., WU A.H., KOLONEL L.N., TEH C.Z., HALPERN J., WEST D.W., PAFFENBARGER R.S. Jr., WHITTEMORE A.S. Prostate cancer susceptibility locus on chromosome 1q:a confirmatory study. J. Natl. Cancer Inst., 1997, 89, 1893-1894.
15. KAPLAN J.C., DELPECH M. La cartographie du génome humain. In biologie moléculaire et médecine, Paris, Flammarion, 1993: 234-69.
16. KEETCH D., RICE J., SUAREZ B., CATALONA W. Familial aspects of prostate cancer: a case control study. J. Urol., 1995, 154, 2100-2102.
17. LESKO S., ROSENBERG L., SHAPIRO S. Family history and prostate cancer risk. Am. J. Epidemiol., 1996, 144:1041-1047.
18. LYNCH J. The genetics and natural history of hereditary colon cancer. Semin. Oncol. Nurs., 1997, 13, 2, 91-8.
19. MANGIN P., CORMIER L., VALERI A. Faut-il dépister le cancer de la prostate. Ann. Urol., 1998, 32, 2, 63-67.
20. McINDOE R.A., STANFORD J.L., GIBBS M., JARVIK G.P., BRANDZEL S., NEAL C.L., LI S., GAMMACK J.T., GAY A.A., GOODE E.L., HOOD L., OSTRANDER E.A. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am. J. Hum. Genet., 1997, 61, 347-353.
21. MONROE K.R., YU M.C., KOLONEL L.N., COETZEE G.A., WILKENS L.R., ROSS R.K., HENDERSON B.E. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nature Med., 1995, 1, 827-829.
22. MORGANTI G., GIANFERRARI L., CRESSERI A., ARRIGONI G., LOVATI G. Recherches clinico - statistiques et génétiques sur les néoplasies de la prostate. Acta genetica Statistica, 1956, 6, 304-305.
23. NAROD S.A., DUPONT A., CUSAN L., DIAMOND P., GOMEZ J.L., SUBURU R.The impact of family history on early detection,of prostate cancer. Nature Med., 1995, 1, 99-101.
24. SCHAID D.J., McDONNEL S.K., BLUTE M.L., THIBODEAU S.N. Evidence for autosomal dominant inheritance of prostate cancer. Am. J. Hum. Genet., 1998, 62, 1425-1438.
25. SMIITH J.R., FREIJE D., CARPTEN J.D., GRONBERG H., XU J., ISAACS S.D., BROWNSTEIN M.J., BOVA G;S., GUO H., BUJNOVSZKY P., NUSSKERN D.R., DAMBER J., BERGH A., EMANUELSSON M., KALLIONIEMI O.P., WALKER-DANIELS J., BAILEY-WILSON J.E., BEATY T.H., MEYERS D.A., WALSH P.C., COLLINS F.S., TRENT J.M., ISAACS W.B. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genomewide search. Science, 1996, 274, 1371-1374.
26. SPITZ M.R., CURRIER R.D., FUEGER J.J., BABAIAN R.J., NEWELL G.R. Familial patterns of prostate cancer: A case control analysis. J. Urol., 1991, 146, 1305-1307.
27. STEINBERG G.D., CARTER B.S., BEATY T.H., CHILDS B., WALSH P.C. Family history and the risk of prostate cancer. The Prostate. 1990, 17, 337-347.
28. THIBODEAU S.N., WANG Z., TESTER D.J., FRENCH A.J., SCHJROEDER J.J., BISSONET A.S., ROBERTS S.G., BLUT M.L., SCHAID D.J., SMITH J.R., TRENT J.M. Linkage analysis at the HPC1 locus in hereditary prostate cancer families. Am.J. Hum. Genet., 1997, Suppl. 61 :A297.
29. VALERI A., BERTHON P., FOURNIER G., BUZZI J.C., BRIOLLAIS L., MERIA P., BLANCHE H., VELLANE-CHANTELOT C., TEILLAC P., DEMENAIS F., MANGIN P., COHEN N., LE DUC A., CUSSENOT O. Etude progène, projet francais d'analyse génétique du cancer de la prostate familial:recrutement et analyse. Prog. Urol., 1996, 6, 226-235.
30. VALERI A., MANGIN P. Epidémio-génétique et diagnostic pré-clinique du cancer de la prostate. Médecine-Thérapeutique, 1998, 4, 359-368.
31. VALERI A., DRELON E., PIZANIAS I., GUILLAUME E., LIM M.P., LAFOURCADE I., MORANT P., BASCHET F., LEHR J., AZZOUZI R., BRIOLLAIS L., LE DUC A., TEILLAC P., BERTHON P., FOURNIER G., MANGIN P., CUSSENOT O. Survenue précoce et autres paramètres épidémiologiques associés aux formes familales et héréditaires de cancer prostatique. Prog. Urol., 1998, 5, sup. 1, 33A.
32. VALERI A., DRELON E., PAISS T., VOGEL W., de PETRICONI R., HAUTMANN R., FOURNIER G., MANGIN P., BERTHON P., CUSSENOT O. Analyse génétique du cancer de la prostate familial: Localisation d'un gène Prédisposant au Cancer de la Prostate (PCaP) sur le chromosome 1q 42.2-43. Prog. Urol., 1999, 9, 680-688.
33. WHITTEMORE A., WU A., KOLONEL L., JOHN E.M., GALLAGHER R.P., HOWE G.R., WEST D.W., T EH C., STAMEY T. Family history and prostate cancer risk in Black, White, and Asian men in the United States and Canada. Am. J. Epidemiol., 1995, 141, 8: 732-740.
34. XU J., MEYERS D., FREIJE D., ISAACS S., WILEY K., NUSSKERN D., EWING C., WILKENS E., BUJNOVSZKY P., BOVA S., WALSH P., ISAACS W., SHLEUTKER J., MATIKAINEN M., TAMMELA T., VISAKORPI T., KALLIONIEMI O., BERRY R., SCHAID D., FRENCH A., McDONNELL S., SCHROEDER J., BLUTE M., THIBODEAU S., GRONBERG H., EMANUELSSON M., DAMBER J., BERG A., JONSSON B., SMITH J., BAILEY-WILSON J., CARPTEN J., STEPHAN D., GILLANDERS E., AMUNDSON I., KAINU T., FREAS-LUTZ D., BAFFOE-BONNIE A., VAN AUCKEN A., SOOD R., COLLINS F., BROWNSTEIN M., TRENT J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat. Genet., 1998, 20, 175-179.